Endothelin-1 Treatment Induces an Experimental Cerebral Malaria–Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65

Yuri C. Martins, Brandi D. Freeman, Oscar B. Akide Ndunge, Louis M. Weiss, Herbert B. Tanowitz, Mahalia S. Desruisseaux

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Plasmodium berghei ANKA infection of C57BL/6 mice is a widely used model of experimental cerebral malaria (ECM). By contrast, the nonneurotropic P. berghei NK65 (PbN) causes severe malarial disease in C57BL/6 mice but does not cause ECM. Previous studies suggest that endothelin-1 (ET-1) contributes to the pathogenesis of ECM. In this study, we characterize the role of ET-1 on ECM vascular dysfunction. Mice infected with 106 PbN-parasitized red blood cells were treated with either ET-1 or saline from 2 to 8 days postinfection (dpi). Plasmodium berghei ANKA–infected mice served as the positive control. ET-1–treated PbN-infected mice exhibited neurological signs, hypothermia, and behavioral alterations characteristic of ECM, dying 4 to 8 dpi. Parasitemia was not affected by ET-1 treatment. Saline-treated PbN-infected mice did not display ECM, surviving until 12 dpi. ET-1–treated PbN-infected mice displayed leukocyte adhesion to the vascular endothelia and petechial hemorrhages throughout the brain at 6 dpi. Intravital microscopic images demonstrated significant brain arteriolar vessel constriction, decreased functional capillary density, and increased blood-brain barrier permeability. These alterations were not present in either ET-1–treated uninfected or saline-treated PbN-infected mice. In summary, ET-1 treatment of PbN-infected mice induced an ECM-like syndrome, causing brain vasoconstriction, adherence of activated leukocytes in the cerebral microvasculature, and blood-brain barrier leakage, indicating that ET-1 is involved in the genesis of brain microvascular alterations that are the hallmark of ECM.

Original languageEnglish (US)
Pages (from-to)2957-2969
Number of pages13
JournalAmerican Journal of Pathology
Volume186
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Plasmodium berghei
Cerebral Malaria
Endothelin-1
Inbred C57BL Mouse
Therapeutics
Blood-Brain Barrier
Brain
Leukocytes
Parasitemia
Intracranial Hemorrhages
Vascular Endothelium
Microvessels
Vasoconstriction
Hypothermia
Constriction
Blood Vessels
Permeability
Theoretical Models
Erythrocytes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Endothelin-1 Treatment Induces an Experimental Cerebral Malaria–Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65. / Martins, Yuri C.; Freeman, Brandi D.; Akide Ndunge, Oscar B.; Weiss, Louis M.; Tanowitz, Herbert B.; Desruisseaux, Mahalia S.

In: American Journal of Pathology, Vol. 186, No. 11, 01.11.2016, p. 2957-2969.

Research output: Contribution to journalArticle

Martins, Yuri C. ; Freeman, Brandi D. ; Akide Ndunge, Oscar B. ; Weiss, Louis M. ; Tanowitz, Herbert B. ; Desruisseaux, Mahalia S. / Endothelin-1 Treatment Induces an Experimental Cerebral Malaria–Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65. In: American Journal of Pathology. 2016 ; Vol. 186, No. 11. pp. 2957-2969.
@article{85b53c861b5c4b0ab43ff2eb63407b9a,
title = "Endothelin-1 Treatment Induces an Experimental Cerebral Malaria–Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65",
abstract = "Plasmodium berghei ANKA infection of C57BL/6 mice is a widely used model of experimental cerebral malaria (ECM). By contrast, the nonneurotropic P. berghei NK65 (PbN) causes severe malarial disease in C57BL/6 mice but does not cause ECM. Previous studies suggest that endothelin-1 (ET-1) contributes to the pathogenesis of ECM. In this study, we characterize the role of ET-1 on ECM vascular dysfunction. Mice infected with 106 PbN-parasitized red blood cells were treated with either ET-1 or saline from 2 to 8 days postinfection (dpi). Plasmodium berghei ANKA–infected mice served as the positive control. ET-1–treated PbN-infected mice exhibited neurological signs, hypothermia, and behavioral alterations characteristic of ECM, dying 4 to 8 dpi. Parasitemia was not affected by ET-1 treatment. Saline-treated PbN-infected mice did not display ECM, surviving until 12 dpi. ET-1–treated PbN-infected mice displayed leukocyte adhesion to the vascular endothelia and petechial hemorrhages throughout the brain at 6 dpi. Intravital microscopic images demonstrated significant brain arteriolar vessel constriction, decreased functional capillary density, and increased blood-brain barrier permeability. These alterations were not present in either ET-1–treated uninfected or saline-treated PbN-infected mice. In summary, ET-1 treatment of PbN-infected mice induced an ECM-like syndrome, causing brain vasoconstriction, adherence of activated leukocytes in the cerebral microvasculature, and blood-brain barrier leakage, indicating that ET-1 is involved in the genesis of brain microvascular alterations that are the hallmark of ECM.",
author = "Martins, {Yuri C.} and Freeman, {Brandi D.} and {Akide Ndunge}, {Oscar B.} and Weiss, {Louis M.} and Tanowitz, {Herbert B.} and Desruisseaux, {Mahalia S.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.ajpath.2016.07.020",
language = "English (US)",
volume = "186",
pages = "2957--2969",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Endothelin-1 Treatment Induces an Experimental Cerebral Malaria–Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65

AU - Martins, Yuri C.

AU - Freeman, Brandi D.

AU - Akide Ndunge, Oscar B.

AU - Weiss, Louis M.

AU - Tanowitz, Herbert B.

AU - Desruisseaux, Mahalia S.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Plasmodium berghei ANKA infection of C57BL/6 mice is a widely used model of experimental cerebral malaria (ECM). By contrast, the nonneurotropic P. berghei NK65 (PbN) causes severe malarial disease in C57BL/6 mice but does not cause ECM. Previous studies suggest that endothelin-1 (ET-1) contributes to the pathogenesis of ECM. In this study, we characterize the role of ET-1 on ECM vascular dysfunction. Mice infected with 106 PbN-parasitized red blood cells were treated with either ET-1 or saline from 2 to 8 days postinfection (dpi). Plasmodium berghei ANKA–infected mice served as the positive control. ET-1–treated PbN-infected mice exhibited neurological signs, hypothermia, and behavioral alterations characteristic of ECM, dying 4 to 8 dpi. Parasitemia was not affected by ET-1 treatment. Saline-treated PbN-infected mice did not display ECM, surviving until 12 dpi. ET-1–treated PbN-infected mice displayed leukocyte adhesion to the vascular endothelia and petechial hemorrhages throughout the brain at 6 dpi. Intravital microscopic images demonstrated significant brain arteriolar vessel constriction, decreased functional capillary density, and increased blood-brain barrier permeability. These alterations were not present in either ET-1–treated uninfected or saline-treated PbN-infected mice. In summary, ET-1 treatment of PbN-infected mice induced an ECM-like syndrome, causing brain vasoconstriction, adherence of activated leukocytes in the cerebral microvasculature, and blood-brain barrier leakage, indicating that ET-1 is involved in the genesis of brain microvascular alterations that are the hallmark of ECM.

AB - Plasmodium berghei ANKA infection of C57BL/6 mice is a widely used model of experimental cerebral malaria (ECM). By contrast, the nonneurotropic P. berghei NK65 (PbN) causes severe malarial disease in C57BL/6 mice but does not cause ECM. Previous studies suggest that endothelin-1 (ET-1) contributes to the pathogenesis of ECM. In this study, we characterize the role of ET-1 on ECM vascular dysfunction. Mice infected with 106 PbN-parasitized red blood cells were treated with either ET-1 or saline from 2 to 8 days postinfection (dpi). Plasmodium berghei ANKA–infected mice served as the positive control. ET-1–treated PbN-infected mice exhibited neurological signs, hypothermia, and behavioral alterations characteristic of ECM, dying 4 to 8 dpi. Parasitemia was not affected by ET-1 treatment. Saline-treated PbN-infected mice did not display ECM, surviving until 12 dpi. ET-1–treated PbN-infected mice displayed leukocyte adhesion to the vascular endothelia and petechial hemorrhages throughout the brain at 6 dpi. Intravital microscopic images demonstrated significant brain arteriolar vessel constriction, decreased functional capillary density, and increased blood-brain barrier permeability. These alterations were not present in either ET-1–treated uninfected or saline-treated PbN-infected mice. In summary, ET-1 treatment of PbN-infected mice induced an ECM-like syndrome, causing brain vasoconstriction, adherence of activated leukocytes in the cerebral microvasculature, and blood-brain barrier leakage, indicating that ET-1 is involved in the genesis of brain microvascular alterations that are the hallmark of ECM.

UR - http://www.scopus.com/inward/record.url?scp=84994893457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994893457&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2016.07.020

DO - 10.1016/j.ajpath.2016.07.020

M3 - Article

VL - 186

SP - 2957

EP - 2969

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 11

ER -